Given the observed involvement of IL-6 and its downstream targets in the regulation of cell proliferation, survival, and metabolism, it is not surprising that IL-6 signaling has also been implicated in tumorigenesis [31], and it has been suggested that it has a possible oncogenic role, driving expression of central hubs in cancer such as STAT3 [32]. The gene discussed is STAT3; the disease is cancer.